GYPC and breast cancer: In the current studies, we utilized CD236/CD44/CD24 for isolation of CIC of breast cancer cells based on previous studies showing that ESA+/CD44+/CD24−or low breast cancer cell subset from human breast cancer tissue and breast cancer cell lines is more tumorigenic and more stem-like behavior.